Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon Mar 04, 2023 7:12pm
80 Views
Post# 35319595

RE:RE:RE:Guidance for Q123 2.5% organic growth! low growth&margins

RE:RE:RE:Guidance for Q123 2.5% organic growth! low growth&margins

2nd try. Bloody SH editor sucks...
 

Prasath Pandurangan

Good morning. Congrats on the quarter. First, just to confirm, have the benefits from the new CMS rates being fully captured in the 1Q guidance? If not, how much further growth in pricing do you see in the upcoming quarters?

Casey Hoyt

Yes. They are in the first quarter guidance. And as I mentioned, I mean, we have some – we have been rather conservative with our bad debt assumptions. We typically reserve at a higher rate in the first quarter than others if you'll go back and look and see last year. So, with insurance changes and reauthorizations and all kinds of things that hit us in the first quarter, we take a conservative view of that. But yes, they have been embedded in our numbers.

 



lscfa wrote: Stop misleading with half truths....



besttobe wrote: What is surprising, is that this guidance includes CMS CPI raise. In other words, growth other than the CMS price increase is less than zero. No wonder the huge selloff. It will take a few Q's before this VMD show me story can be told. Dead money until then....IMO



 

<< Previous
Bullboard Posts
Next >>